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Abdominal obesity is a major risk factor for insulin resistance, type 2 diabetes and cardiovascular diseases. Dietary
fat induces insulin resistance in humans and rodents. The current study investigates whether a Chlorogenic acid/
Chromium III supplement rescues obesity and insulin resistance caused by high-fat feeding of male C57BL/6 J mice
for 7 weeks. Administering an oral daily dose of this supplement in the last 3 weeks of feeding reversed diet-induced
body weight gain and insulin resistance, assessed by hyperglycemia, glucose intolerance and insulin intolerance.
Indirect calorimetry analysis revealed that this effect is mediated at least partly, by increasing energy expenditure and
spontaneous locomoter activity. These findings underscore the important role that chlorogenic acid and chromium
play in maintaining glucose metabolism and insulin response in mice fed a high-fat diet.Background
The prevalence of visceral obesity has steadily increased
worldwide. Currently, the majority of Americans are
overweight and nearly 35 % are obese [1, 2]. Because ab-
dominal obesity constitutes an increased risk of develop-
ing type 2 diabetes and fatty liver disease that are
spreading at an epidemic rate [3], it has become impera-
tive to develop means that could be easily introduced to
our daily lives to fight efficiently the spread of this
disease.
Abdominal obesity is commonly associated with per-
ipheral insulin resistance, a hallmark of metabolic syn-
drome and related diseases. Peripheral insulin resistance
is multifactorial and is manifested by hyperinsulinemia
and random hyperglycemia in addition to glucose and
insulin intolerance [4]. The cause-effect relationship be-
tween obesity and insulin resistance has been a subject
of intense investigation. It has been widely accepted that
increase in caloric burden promotes lipid storage in
white adipose tissue (WAT), causing visceral obesity* Correspondence: sonia.najjar@utoledo.edu
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sistance is mediated by several mechanisms, including
the release of WAT-derived fatty acids and adipokines
that blunt insulin signaling and cause ectopic lipotoxicity
and a systemic pro-inflammatory state [5]. This also re-
duces adiponectin release from WAT, an event that con-
tributes to the insulin resistance state caused by high-fat
intake [6].
Reciprocally, several laboratories, including ours, have
reported on the metabolic and cardiovascular benefits of
caloric restriction and exercise in humans and rat
models of metabolic syndrome [7–9]. However, abun-
dance of food supply and the more favored sedentary life
style have rendered weight loss a continuous challenge
to inhabitants of the industrialized world. A large num-
ber of beverages and foods containing no-calorie or low-
calorie (e.g., artificial or indigestible) sweeteners have been
developed in recent years. However, these have failed to
control body weight loss efficiently, owing to complex
body feedback systems that may eventually stimulate food
craving and excessive caloric intake [10, 11].
Polyphenols containing natural products exert an anti-
diabetic effect [12]. Coffee contains the highest concen-
tration of polyphenols among other beverages [13].
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phora Pierre (commonly known as green coffee beans).
CGA has many biological properties (i.e. antioxidant) [14]
and insulin-sensitizing activities [15]. It also reduces
hyperglycemia via several mechanisms [16]. These include
stimulating glucagon-like peptide 1–mediated insulin se-
cretion [17] and activating AMP-dependent kinase to pro-
mote translocation of glucose transporter 4 to the plasma
membrane for glucose uptake [18].
Yet, increased consumption of coffee alone may be
counter effective in some individuals, as caffeine can
cause sleep deprivation, which in turn, causes obesity
and insulin resistance [19–21]. Thus, coffee was supple-
mented with CGA and chromium III (CrIII), a rapidly
absorbed chromium form with an anti-inflammatory ef-
fect [22], to investigate whether this CGA/Cr formula-
tion reverses the metabolic abnormalities induced by
high-fat diet in C57BL/6 J (BL6) mice, an animal model
that responds metabolically to dietary fat like humans
[23]. We herein demonstrate that supplementing diet
with daily oral gavage of CGA/Cr for 3 weeks reversed
diet-induced obesity, hyperglycemia and insulin resist-
ance, and that this is mediated at least in part, by in-




C57BL/6 J (BL6) male mice (3 months of age) were fed
ad libitum either a standard regular diet (RD) deriving
12: 66: 22 % calories from fat: carbohydrate: protein, or a
high-fat diet (HF) deriving 45: 35: 20 % calories from fat:
carbohydrate: protein (D12451, Research Diets, New
Brunswick, NJ). Fatty acid composition in HF diet was
36: 45: 19 % saturated (SFA): monounsaturated (MUFA):
polyunsaturated fatty acids (omega-6 PUFA). Mice were
kept in a 12-h-dark/light cycle, and the Institutional Animal
Care and Utilization Committee approved all procedures.
Treatment
Mice were fed either HF or RD for 7 weeks. In the last
3 weeks of feeding, RD-fed mice were treated with water
alone while HF-fed mice were treated with water, a
CGA/Cr supplement or with CGA alone. The CGA/Cr
supplement contained base caffeine [0.1 mg/mouse/day
caffeine (Boresha International Inc.), 0.1 mg/mouse/day
Vitamin C (Sigma-Aldrich, St. Louis, MO) and 5.13 mg/
mouse/day fructose (Sigma-Aldrich)] in addition to
2.3 μg/mouse/day chromium dinicocysteinate (Cr) (Inter
Health, Benecia, CA) [24] and 0.21 mg/mouse/day
decaffeinated Phenol-Chlorogenic Acid comprising 3-O-
caffeoylquinic acid (3-CQA), 4-CQA and 5-CQA (Naturex
SA, Avignon, France) [25]. Chromium was removed from
the supplement designated as CGA alone. Doses weresimilar to those used in humans adjusted to 40 g body
weight/mouse. Mice were fasted daily for one hour before
they were subjected at 1500 h to a once daily oral gavage
of 0.5 ml of water, CGA or CGA/Cr, using a feeding tube.
The approach of fasting and using 0.5 ml was designed to
avoid aspirations.
Intra-peritoneal insulin tolerance test
As previously described [26], mice were fasted for 7 h start-
ing at 700 h. Human insulin Novolin (Novo Nordisk NDC
0169-1833-11) was administered intraperitoneally (IP) at
0.75 U/kg BW to awake mice. Blood glucose was measured
from the tail vein by snipping the tail at 0–180 min post-
insulin injection. Glucose levels were expressed as percent-
age to fasting levels.
Intra-peritoneal glucose tolerance test
As previously described [26], mice were fasted overnight
(from 1700 to 800 h the following day), and glucose was
administered IP at 1.5 g/kg BW (50 % dextrose solution)
to awake mice. Blood glucose level (mg/dl) was measured
from the tail vein at 0–120 min post-glucose injection.
Indirect calorimetry analysis
Indirect calorimetry and food intake were assessed in in-
dividually caged (CLAMS system, Columbus Instrument,
Columbus, OH) awake mice at the end of the treatment
period (n = 4/group), over a 3-day period after being ac-
climated for 2 days, as described [27]. Mice had access
to food and water ad libitum. Spontaneous locomotor
activity was measured with an optical beam measuring
horizontal and vertical movement (XYZ-axis). Oxygen
consumption (VO2) and CO2 production (VCO2) were
sampled every 30 min. Data were represented as mean ±
SEM of light (600-1800 h) and dark (1800 h-600 h)
cycles.
Statistical analysis
Using GraphPad Prism 4 software, data were analyzed with
one-way analysis of variance (ANOVA) with Bonferroni
correction in all figures except for data in Fig. 1, which
were analyzed by student t-test. P <0.05 was statistically
significant.
Results
CGA/Chromium III and CGA supplements reversed
diet-induced obesity
As Fig. 2 reveals, feeding mice a fat-rich diet (HF) for
4 weeks caused an increase in body weight relative to
mice fed a regular diet (RD) (dark circles versus white
squares). Supplementation with CGA/Cr (gray circles)
and CGA (hatched circles) prevented further gain in
body weight and instead, reduced it significantly within
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Fig. 1 Effect of 4 weeks of High-fat Diet on Insulin Tolerance. Mice were fed either a RD (squares) or HF diet (circles) for 4 weeks before being
subjected to an intra-peritoneal insulin tolerance test to assess glucose disposal at 0–180 min post-insulin injection. The area under the curve
(AUC) was measured from each graph and presented in the bar graphs (panels ii) to the right. Values are expressed as mean ± SEM. *P <0.05
versus RD-water
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circles versus white squares).
CGA/Chromium III supplement reversed all of the
metabolic abnormalities induced by high-fat diet
In addition to obesity (Fig. 2), 4 weeks of HF diet caused
insulin resistance, as shown by increased intolerance to
exogenous insulin relative to mice fed RD (Fig. 1,i black
circles versus white squares, and Fig. 1,ii in the accom-
panying bar graph depicting the Area Under the Curve
(AUC): 14287 ± 458 in HF-water (black bar) versus
11182 ± 691.9 arbitrary units (au) in RD-water (white
bar); P <0.05).
To investigate whether CGA/Cr reverses diet-induced
insulin resistance, we administered a daily oral dose of
this supplement (or water alone) to HF-fed mice for
3 weeks as they continued to have free access to dietary
fat. 7 weeks of HF feeding caused insulin intoleranceCGA/Cr and CGA Reverse Diet-Induce





















Fig. 2 Effect of CGA/Chromium III Supplement on Body Weight. Male BL6
or a high-fat (HF) diet (circles) (n = 23 mice) for 1 month. HF-fed mice we
daily for 3 weeks with either vehicle (water) (black circles, n = 7 mice), CG
circles, n = 8 mice). RD-fed mice (n = 7) underwent gavage with water alo
treatment period. Body weight was measured weekly over the treatment
RD-water and †versus HF-waterrelative to RD [Fig. 3a,i- black circles versus white
squares and Fig. 3a,ii- AUC: 13611 ± 122 in HF-water
(black bar) versus 10191 ± 529 au in RD-water (white
bar); P <0.05]. CGA/Cr supplementation reduced diet-
induced insulin intolerance (Fig. 3a,i- gray versus black
circles), as demonstrated by lower AUC levels [Fig. 3a,
ii- AUC: 11780 ± 524 in HF-CGA/Cr (gray bar) versus
13611 ± 122 au in HF-water (black bar); P <0.05]. Fur-
thermore, CGA/Cr restored insulin tolerance in these
HF-fed mice to a level comparable to that in mice fed a
regular diet (RD-Water) [Fig. 3a,i- gray circles versus
white squares and Fig. 3a,ii- AUC: 11780 ± 524 in HF-
CGA/Cr (gray bar) versus 10191 ± 529 au in RD-water
(white bar)]. In contrast to CGA/Cr, CGA alone did not
reverse significantly insulin intolerance [Fig. 3a,i- hatched
circles versus white squares and Fig. 3a,ii- AUC: 12909 ±
1126 in HF-CGA (hatched bar) versus 10191 ± 529 au in






mice (3 months of age) were fed a regular (RD) (squares) (n = 7 mice)
re then subjected (dashed vertical line) to gavage treatment once
A (hatched circles, n = 8 mice) or CGA/Chromium III (CGA/Cr) (gray
ne. Mice continued to have full access to the same diets during the

















































































a. CGA/Cr Curbs Diet-Induced Insulin Intolerances
b. CGA/Cr and CGA Curb Diet-Induced Glucose Intolerance
c. CGA/Cr Curbs Diet-induced hyperglycemia
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Fig. 3 CGA/Chromium III Supplement Curbs Diet-induced Metabolic Abnormalities. Mice were fed for 4 weeks with RD (squares) or HF (circles)
before receiving an oral gavage of water (black circles), CGA alone (hatched circles) and CGA/Chromium III (CGA/Cr) (gray circles), once daily
as they continued to be fed the same diet for additional 3 weeks, as in the legend to Fig. 2. At the end of treatment, mice (n = 7-8 per each
treatment per feeding group) were subjected to: a an intra-peritoneal insulin tolerance test to assess glucose disposal at 0–180 min post-insulin
injection, b an intra-peritoneal glucose tolerance test to examine glucose disposal at 0–120 min post glucose injection, and (c) fed blood glucose
levels. For (a-b), the area under the curve (AUC) was measured from each graph and presented in the bar graphs (panels ii) to the right of
each graph in (a) and (b). Values are expressed as mean ± SEM. *P <0.05 versus RD-water (white bars), †versus HF-water (black bars), and §
versus HF-CGA (hatched bars)
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RD feeding [Fig. 3b,i- black circles versus white squares
and Fig. 3b,ii- AUC: 34706 ± 2906 in HF-water (black bar)
versus 24434 ± 1929 au in RD-water (white bar); P <0.05].
CGA/Cr supplementation in the last 3 weeks of HF feed-
ing curbed glucose intolerance [Fig. 3b,i- gray versus black
circles and Fig. 3b,ii- AUC: 28137 ± 2048 in HF-CGA/Cr
(gray bar) versus 34706 ± 2906 au in HF-water (black
bar); P <0.05], and restored it to a level comparable to that
in RD-fed mice [Fig. 3b,ii- AUC: 28137 ± 2048 in HF-
CGA/Cr (gray bar) versus 24434 ± 1929 au in RD-water(white bar)]. Similarly, CGA supplementation (Fig. 3b,
i- hatched circles) restored glucose tolerance [Fig. 3b,
ii- AUC: 29212 ± 1113 in HF-CGA (hatched bars) versus
24434 ± 1929 au in RD-water (white bars)].
As expected, HF feeding caused fed hyperglycemia
[Fig. 3c- 127 ± 2.15 in HF-water (black bar) versus 96.7 ±
4.02 mg/dl in RD-water (white bar); P <0.05]. CGA/Cr sup-
plementation restored fed glucose levels [Fig. 3c- 107 ±
1.91 in HF-CGA/Cr (gray bar) versus 96.7 ± 4.02 mg/dl in
RD-water (white bar)]. In contrast, CGA failed to reverse
fed hyperglycemia, as assessed by persistently higher
Fig. 4 Indirect Calorimetry Analysis. At the end of the treatment
period, mice were individually placed in calorimetric cages (n = 4/
treatment group) with free access to food and water for 2 days to
acclimate followed by indirect calorimetry analysis in a 24 h-period
for 3 days to measure: a Food Intake (food g/mouse/ day), b Energy
Expenditure (kcal/h/kg BW), and c Spontaneous locomotor activity
(events/h) in each of the light (from 600 to 1800 h) and dark (from
1800 to 600 h-Gray shaded) cycle. Values are expressed as mean ±
SEM of each time interval in the last 3 days. *P <0.05 versus RD-water
(white bars) and †versus HF-water (black bars)
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CGA (hatched bar) versus 96.7 ± 4.02 in RD-water (white
bars); P <0.05].
CGA/Chromium III supplement protects against
diet-induced decrease in energy expenditure
Indirect calorimetry analysis over a 24 h-period revealed
that HF feeding markedly reduced daily food intake,
which is more typically intense in the dark cycle (Fig. 4a).
HF feeding also reduced energy expenditure (Fig. 4b) as
well as the spontaneous locomoter activity in these mice
(Fig. 4c). CGA/Cr supplementation did not affect food
intake (Fig. 4a), but remarkably restored energy expend-
iture (Fig. 4b) and the physical activity (Fig. 4c) of HF-
fed mice, in particular in the dark cycle. Of note, CGA/
Cr supplementation induced the physical activity of HF-
fed mice even in the light cycle (Fig. 4c, gray versus
black bars).
Discussion
Obesity is a global epidemic and a major risk factor for
metabolic and cardiovascular diseases. Dietary fat is a key
player in the induction of insulin resistance in humans [28]
and mice [29]. The current studies aimed to determine the
effect of CGA/Cr supplement containing chlorogenic acid
on diet-induced body weight gain and insulin resistance in
BL6 mice. We herein show that CGA/Cr formulation re-
verses body weight gain in addition to insulin and glucose
intolerance in mice fed a high-fat diet. This effect appears
to be mediated, at least in part, by increasing spontaneous
locomoter activity and energy expenditure.
The current study provides evidence that CGA/Cr for-
mulation constitutes a unique alimentary combination
that promotes energy expenditure and maintains physio-
logic insulin response even in the face of prolonged
high-fat intake. This is in agreement with other reports
showing the positive regulatory effect of CGA on glu-
cose metabolism and insulin action in mice [15]. For in-
stance, Murasi et al. [30] showed that coffee polyphenols
reduced fat accumulation in BL6 mice fed a high-fat diet
for 15 weeks by increasing energy metabolism and redu-
cing lipogenesis in liver. These studies differ from ours
insofar as they implicated the supplementation of the
diet with purified polyphenols at the beginning of the
feeding regimen, supporting a preventive effect of poly-
phenols on the metabolic derangement caused by long-
term consumption of fat-enriched diet. However, other
reports [31, 32] revealed that CGA supplementation did
not attenuate obesity, glucose intolerance and insulin re-
sistance in BL6 mice fed a high-fat diet for 12 weeks, al-
though it improved endothelial dysfunction. The different
methods of CGA administration may explain some of
these disparities. In those studies, CGA was supplemented
with the high-fat diet over a period of 12 weeks at 0.5 %weight/weight CGA in [31] and 1 g of CGA/kg of diet in
[32]. Because mice were presumably housed in groups in
those studies, the CGA dose each mouse ingested may
not be as clearly defined as in our studies that implicated
CGA/Cr administration by gavage to ascertain equal dose
delivery to each mouse at the end of the light cycle.
More importantly, CGA was not administered alone
in our studies, but rather, it was supplemented with
other ingredients such CrIII. Because CrIII is a potent
hypoglycemic compound that bears an anti-inflamma-
tory activity [33], it is likely that it contributed to the
effectiveness of the CGA/Cr formulation in reversing at
least some of the metabolic abnormalities caused by
high-fat diet. Administering CGA alone without CrIII
fully restored body weight and glucose tolerance, but not
insulin tolerance or fed glucose levels, which remained
Ghadieh et al. Nutrition & Metabolism  (2015) 12:19 Page 6 of 7significantly different from RD-fed mice treated with
water alone. While few studies failed to detect an insulin-
sensitizing role for chromium in humans [34] and rats fed
a high-fat diet for 8 weeks [35], several others highlighted
its metabolic benefits. For instance, it has been shown to
reduce hyperglycemia and attenuate insulin resistance in
part, by inhibiting the ubiquitin-proteasome pathways me-
diating degradation of insulin receptor substrate 1 and 2,
critical mediators of insulin signaling [22]. CrIII has also
been shown to elevate circulating vitamin C and adipo-
nectin levels, and to inhibit the inflammatory pathways in
type 2 diabetic rats [24] and humans [36]. Our data under-
score the complementary benefit of combining CGA to
CrIII in terms of body weight loss and preserving insulin
response during sustained high-fat intake, which com-
monly causes insulin resistance and visceral obesity. Add-
ing Vitamin C to CGA/Cr formulation could potentiate
the hypoglycemic effect of CrIII [24, 36].
Of note, CGA/Cr did not increase food intake, as would
be expected of the glucose-lowering effect of CrIII, and of
the addition of fructose, a low glycemic carbohydrate that
does not stimulate a significant release of satiety hor-
mones such as insulin and leptin [37, 38]. Despite prevail-
ing controversy around the negative metabolic effect of
fructose in humans and mice [39], this carbohydrate did
not appear to counter-regulate the overall protective ef-
fects of the CGA/Cr formulation used in our studies. It is
possible that the low dose of fructose used (~0.125 mg/kg
body weight) limited its adverse metabolic effect, in par-
ticular in the presence of CGA that could conversely,
overcome its negative effect [40].
As expected, indirect calorimetric analysis shows that
high-fat feeding reduces food intake, energy expenditure
and physical activity compared to mice fed a regular
diet. CGA/Cr supplementation restored energy expend-
iture and the physical activity of HF-fed mice without af-
fecting food intake. This thermogenic effect of CGA/Cr
is likely to be due to CGA [30] and to caffeine [41]. The
underlying molecular mechanisms are not known, but
polyphenols induce CEACAM1 [42], a protein that pro-
motes insulin sensitivity by mediating insulin clearance
in liver [43]. We have observed that high-fat diet reduces
CEACAM1 and that transgenic overexpression of CEA-
CAM1 in liver prevents the negative effect of high-fat
diet on energy expenditure and physical activity in mice
[44]. Thus, it is reasonable to speculate that induction of
hepatic CEACAM1 by polyphenols contributes to the
restoration of insulin sensitivity, energy expenditure and
spontaneous locomoter activity caused by CGA/Cr ad-
ministration. It is also possible that administering this
formulation increases spontaneous physical activity and
energy expenditure (by activating sympathetic nervous
outflow to adipose tissue) and this in turn, promotes in-
sulin sensitivity [27].In summary, the current studies provide evidence that
this caffeine-based CGA/Chromium III formulation curbs
the adverse effect of high-fat diet on body weight and in-
sulin action in mice. Given that the metabolic response of
BL6 mice to high-fat diet simulates that of humans, the
data suggest that this CGA/Chromium III formulation
could serve as a promising alimentary supplement to
facilitate weight control with consumption of a fat-
enriched diet. More studies are needed to investigate the
underlying molecular and cellular mechanisms. Nonethe-
less, the current report demonstrates the important role
of increased energy expenditure and physical activity by
daily CGA/Chromium III consumption in preventing
body weight gain and insulin resistance in response to
high-fat intake.Conclusions
We herein identify a caffeine-based CGA/Chromium III
formulation that curbs the adverse effect of high-fat diet
on body weight and insulin action in mice. This is partly
mediated by preserving energy expenditure and spontan-
eous physical activity.
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